Cargando…
Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
SIMPLE SUMMARY: Radiotherapy is an important component of cancer treatment, given to around half of all cancer patients. Radiotherapy is known to be very effective at directly killing cancer but, until recently, the important effects that radiotherapy has on the surrounding immune cells were not wid...
Autores principales: | Romano, Erminia, Honeychurch, Jamie, Illidge, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865752/ https://www.ncbi.nlm.nih.gov/pubmed/33530329 http://dx.doi.org/10.3390/cancers13030457 |
Ejemplares similares
-
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020) -
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
por: Frankish, Jamie, et al.
Publicado: (2023) -
Synchronous apoptosis in established tumors leads to the induction of adaptive immunity
por: Honeychurch, Jamie, et al.
Publicado: (2013) -
How is the IFSPT Bridging the Gap Between Science and Clinical Practice?
por: Damsbo, Lars, et al.
Publicado: (2022) -
Hypoxia imaging and radiotherapy: bridging the resolution gap
por: Grimes, David Robert, et al.
Publicado: (2017)